All Comments by
- David Teplow on Aggregation and catabolism of disease-associated intra-Abeta mutations: reduced proteolysis of AbetaA21G by neprilysin.
- Patricia C. Heyn on Cardiorespiratory fitness and brain atrophy in early Alzheimer disease.
- Mark Cookson on A PD Trifecta: Synuclein Gene Expression, Aging, and Inflammation
- Paul Coleman on Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial.
- Paul Coleman on Widespread changes in dendritic spines in a model of Alzheimer's disease.
- Paul Coleman on Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.
- Terrence Town on AD Clinical Pipeline: Immunotherapy Woes, Dimebon Boons
- Elena Galea on Research Brief—Flurizan Fails Final Hurdle, Company Discontinues Drug
- Avi Friedlich on A PD Trifecta: Synuclein Gene Expression, Aging, and Inflammation
- Julie Andersen on A PD Trifecta: Synuclein Gene Expression, Aging, and Inflammation
- Stuart Kim on A PD Trifecta: Synuclein Gene Expression, Aging, and Inflammation
- Volkmar Lessmann on Distinct role of long 3' UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons.
- Leonidas Stefanis on Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease.
- Todd E. Golde on AD Clinical Pipeline: Immunotherapy Woes, Dimebon Boons
- George Martin on Age-specific epigenetic drift in late-onset Alzheimer's disease.